LakeShore Biopharma Co Operating Income

Latest operating income for YS: $-450M.

Get informed when a big investor buys or sells

+ Follow

Quarterly Operating Income

$-181145517.00

As of Mar 31, 2024

Annual Operating Income (TTM)

$-446070517.00

Trailing 12 months ending Mar 31, 2024

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin

LakeShore Biopharma Co (YS) FAQ

As of the most recent data (March 2024), YS shows a operating income of $-450M. Scroll down for historical charts and peer comparison views.

Tracking YS's operating income over time shows whether LakeShore Biopharma Co is scaling, shrinking, or reshaping that part of the business. The current reading is $-450M Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this operating income page, Stockcircle has LakeShore Biopharma Co's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect operating income (currently $-450M) with ownership activity and broader fundamentals.